Atlas Trials

Double-Negative Prostate Carcinoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Double-Negative Prostate Carcinoma

RecordFirmDate
Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer (NCT03999515)University of Washington2020-04-27

Track Double-Negative Prostate Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.